<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2005-11-1-34-38</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Влияние антигипертензивной терапии на функциональное состояние системы гипофиз-гонады у пациентов с артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Impact of antihypertensive therapy on the functional state of the pituitary-gonadal system in patients with arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Санкт-Петербургская медицинская академия последипломного образования</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2005</year></pub-date><volume>11</volume><issue>1</issue><fpage>34</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Иванов Н.В., 2005</copyright-statement><copyright-year>2005</copyright-year><copyright-holder xml:lang="ru">Иванов Н.В.</copyright-holder><copyright-holder xml:lang="en">Ivanov N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1004">https://htn.almazovcentre.ru/jour/article/view/1004</self-uri><abstract><p>Целью работы было изучение влияния гипотензивной терапии блокаторами медленных кальциевых каналов, ингибиторами ангиотензинпревращающего фермента (ИАПФ) и блокаторами ß-адренергических рецепторов на метаболизм и содержание в крови основных андрогенов надпочечников и гонад, а также уровень инсулинорезистентности у мужчин с артериальной гипертензией (АГ) Обследован 91 пациент с АГ и 15 здоровых паритетных по возрасту мужчин, составивших контрольную группу У мужчин с АГ, получавших терапию блокаторами медленных кальциевых каналов или ИАПФ, выявлено снижение уровня инсулина, повышение уровней дегидроэпиандростерона-сульфата и свободного тестостерона на 30-й день лечения У мужчин с АГ, получавших терапию блокаторами ß-адренергических рецепторов, выявле но повышение уровня инсулина и снижение уровней основных надпочечниковых и тестикулярных андрогенов в сравнении с показателями до начала лечения Уровни гонадотропных гормонов, эстрадиола и кортизола не изменялись под влиянием терапии и не отличались в сравниваемых группах Наличие наследственной отягощенности по АГ оказывает модулирующее влияние на гормональный ответ у мужчин с АГ под влиянием гипотензивной терапии </p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to evaluate the impact of antihypertensive therapy with slow calcium-channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and ß-adrenergic receptor blockers on the metabolism and blood levels of major adrenal androgens and gonads, as well as the insulin resistance in males with arterial hypertension (AH) Ninety-one patients with AH and 15 age-matched healthy male controls were examined The hypertensive males treated with slow calcium-channel blockers or ACE inhibitors were found to have a lower level of insulin and higher levels of dehydroepiandrosterone sulfate and free testosterone on the 30th day of treatment Those on blockers were observed to have a higher level of insulin and lower levels of major adrenal and testicular androgens as compared with their baseline levels Therapy did not alter the levels of gonadotropic hormones, estradiol, and cortisol and they did not differ in the compared groups The family history of AH has a modulating effect on a hormonal response in males with AH treated with antihypertensive agents </p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>андрогены</kwd><kwd>тестостерон</kwd><kwd>дегидроэпиандростерон</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>androgens</kwd><kwd>testosterone</kwd><kwd>dehydroepiandrosterone</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fogan R., Zoppi A., Preti P. et al. Sexual activity and plasma testosterone levels in hypertensive males Am J Hypertens 2002 15 137-44</mixed-citation><mixed-citation xml:lang="en">Fogan R., Zoppi A., Preti P. et al. Sexual activity and plasma testosterone levels in hypertensive males Am J Hypertens 2002 15 137-44</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jaffe A., Chen Y., Kisch E.S. et al. Erectile dysfunction m hypertensive subjects Assessment of potential determinants Hypertension 1996 28 859-62</mixed-citation><mixed-citation xml:lang="en">Jaffe A., Chen Y., Kisch E.S. et al. Erectile dysfunction m hypertensive subjects Assessment of potential determinants Hypertension 1996 28 859-62</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">English K.M., Steeds R.P. et al. Low dose transdermal testosterone therapy improves angina threshold m men with chronic stable angina Circulation 2000 102 1906-11</mixed-citation><mixed-citation xml:lang="en">English K.M., Steeds R.P. et al. Low dose transdermal testosterone therapy improves angina threshold m men with chronic stable angina Circulation 2000 102 1906-11</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Channer K.S., Jones T.H. Cardiovascular effects of testosterone implications of the male menopause Heart 2003 89 121-2</mixed-citation><mixed-citation xml:lang="en">Channer K.S., Jones T.H. Cardiovascular effects of testosterone implications of the male menopause Heart 2003 89 121-2</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jacob S., Rett К., Hemnksen E.J. Antihypertensive therapy and msulm sensi twity do we have to redefine the role ofb blocking agents? Am J Hypertens 1998 11 1258-65</mixed-citation><mixed-citation xml:lang="en">Jacob S., Rett К., Hemnksen E.J. Antihypertensive therapy and msulm sensi twity do we have to redefine the role ofb blocking agents? Am J Hypertens 1998 11 1258-65</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Goyal R.K. Hypennsulmemia and msulm resistance m hypertension dif ferential effects of antihypertensive agents Clm Exp Hypertens 1999 21 167-79</mixed-citation><mixed-citation xml:lang="en">Goyal R.K. Hypennsulmemia and msulm resistance m hypertension dif ferential effects of antihypertensive agents Clm Exp Hypertens 1999 21 167-79</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sowers J.R. Effects of calcium antagonists on msulm sensitivity and other metabolic parameters Am J Cardiol 1997 79 24-8</mixed-citation><mixed-citation xml:lang="en">Sowers J.R. Effects of calcium antagonists on msulm sensitivity and other metabolic parameters Am J Cardiol 1997 79 24-8</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki H., Tommaga T., Kumagai H. et al. Effects of first line antihyperten swe agents on sexual function and sex hormones J Hypertens 1988 6 649-51</mixed-citation><mixed-citation xml:lang="en">Suzuki H., Tommaga T., Kumagai H. et al. Effects of first line antihyperten swe agents on sexual function and sex hormones J Hypertens 1988 6 649-51</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Beer N.A., Jakubowicz D.J., Beer R.M. et al. Effects of nitrendipine on glucose tolerance and serum msulm and dehydroepiandrosterone sulfate levels m insulin-resistant obese and hypertensive men.J Clin Endocrinol Metab 1993; 76:178-83.</mixed-citation><mixed-citation xml:lang="en">Beer N.A., Jakubowicz D.J., Beer R.M. et al. Effects of nitrendipine on glucose tolerance and serum msulm and dehydroepiandrosterone sulfate levels m insulin-resistant obese and hypertensive men.J Clin Endocrinol Metab 1993; 76:178-83.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Caro J.F. Insulin resistance in obese and nonobese men.J Clin Endocrinol Metab 1991; 73: 691-5·</mixed-citation><mixed-citation xml:lang="en">Caro J.F. Insulin resistance in obese and nonobese men.J Clin Endocrinol Metab 1991; 73: 691-5·</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bohlen L., Bienz R,, Diser M. et al. Metabolic-neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.J Cardiovasc Pharmacol 1996; 27: 770-6.</mixed-citation><mixed-citation xml:lang="en">Bohlen L., Bienz R,, Diser M. et al. Metabolic-neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.J Cardiovasc Pharmacol 1996; 27: 770-6.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Galletti F., Strazzullo P., Capaldo В. et al. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).J Нуpertens 1999; 17:439-45</mixed-citation><mixed-citation xml:lang="en">Galletti F., Strazzullo P., Capaldo В. et al. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).J Нуpertens 1999; 17:439-45</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Draznin B., Sussman K.E., Eckel R.H. et al. Possible role of cytosolic free calcium concentrations in mediating insulin résistons of obesity and byperinsulinemia.J Clin Invest 1988; 82:1848-52.</mixed-citation><mixed-citation xml:lang="en">Draznin B., Sussman K.E., Eckel R.H. et al. Possible role of cytosolic free calcium concentrations in mediating insulin résistons of obesity and byperinsulinemia.J Clin Invest 1988; 82:1848-52.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nestler J.E., McClanahan M.A., Clore J.N., Blackard W.G. Insulin inhibits adrenal 1720-lyase activity in man. J Clin Endocrinol Metab 1992; 74: 362-7.</mixed-citation><mixed-citation xml:lang="en">Nestler J.E., McClanahan M.A., Clore J.N., Blackard W.G. Insulin inhibits adrenal 1720-lyase activity in man. J Clin Endocrinol Metab 1992; 74: 362-7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lin T., Haskell Y., Vinson N., Terracio L. Characterization of insulin and insulin like growth factor I receptor of purified Ley dig cells and their role in steroidogenesis in primary culture: comparative study. Endocrinology 1986; 119: 1641-7.</mixed-citation><mixed-citation xml:lang="en">Lin T., Haskell Y., Vinson N., Terracio L. Characterization of insulin and insulin like growth factor I receptor of purified Ley dig cells and their role in steroidogenesis in primary culture: comparative study. Endocrinology 1986; 119: 1641-7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ворохобина H.B., Сильницкий П.А., Рыбкина Е.В. Функциональное состояние системы гипоталамус-гипофиз-гонады у мужчин с сахарным диабетом и с заболеваниями щитовидной железы. Пробл. эндокринол. 1990; 6:34-8</mixed-citation><mixed-citation xml:lang="en">Ворохобина H.B., Сильницкий П.А., Рыбкина Е.В. Функциональное состояние системы гипоталамус-гипофиз-гонады у мужчин с сахарным диабетом и с заболеваниями щитовидной железы. Пробл. эндокринол. 1990; 6:34-8</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Endre T., Mattiason I. et al. Low testosterone and insulin resistance in hypertension prone men. J Hum Hypertens 1996; 10: 755-76.</mixed-citation><mixed-citation xml:lang="en">Endre T., Mattiason I. et al. Low testosterone and insulin resistance in hypertension prone men. J Hum Hypertens 1996; 10: 755-76.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Neuter J.M., Smith D.H., Graettinger W.F. et al. Metabolic characteristics of hypertension: importance of a positive family history. Am Heart J 1993; 126:924-9.</mixed-citation><mixed-citation xml:lang="en">Neuter J.M., Smith D.H., Graettinger W.F. et al. Metabolic characteristics of hypertension: importance of a positive family history. Am Heart J 1993; 126:924-9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Pandei K.N., Oliver P.M., Maeda N., Smithies O. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A knockout and gen-duplicated mutant mouse models. Endocrinology 1999; 140: 5112-9.</mixed-citation><mixed-citation xml:lang="en">Pandei K.N., Oliver P.M., Maeda N., Smithies O. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A knockout and gen-duplicated mutant mouse models. Endocrinology 1999; 140: 5112-9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
